June 2022 Publications
- A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies. Buzitskaya Z, Stosman K, Khairullin B, Kassenov M, Nurpeisova A, Abylai Sansyzbay A, Shurygina AP, Aleksandrov A, Sivak K, Stukova M. Drug Res (Stuttg). 2022 Jun. doi: 10.1055/a-1785-3936. Epub 2022 Mar 22.
- A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV. Warr AJ, Anterasian C, Shah JA, De Rosa SC, Nguyen FK, Maleche-Obimbo E, Cranmer LM, Matemo D, Mecha J, Kinuthia J, LaCourse SM, John-Stewart GC, Hawn TR. EBioMedicine. 2022 Jun. doi: 10.1016/j.ebiom.2022.104023. Epub 2022 May 6.
- Recent developments in systems biology and genetic engineering toward design of vaccines for TB. Singh Y, Beamer G, Sun X, Shukla P. Crit Rev Biotechnol. 2022 Jun. doi: 10.1080/07388551.2021.1951649. Epub 2021 Oct 12.
- Does BCG vaccination protect against infection with M. tuberculosis? Pelzer PT, Smit Y, Tiemersma EW, Huong NT, Nhung NV, Cobelens F. Int J Tuberc Lung Dis. 2022 Jun 1. doi: 10.5588/ijtld.21.0607.
- Insight Into Novel Anti-tuberculosis Vaccines by Using Immunoinformatics Approaches. Khan Z, Ualiyeva D, Amissah OB, Sapkota S, Hameed HMA, Zhang T. Front Microbiol. 2022 Jun 2. doi: 10.3389/fmicb.2022.866873. eCollection 2022.
- Comparison of the Immunogenic Properties of Lactiplantibacillus plantarum Carrying the Mycobacterial Ag85B-ESAT-6 Antigen at Various Cellular Localizations. Wiull K, Boysen P, Kuczkowska K, Moen LF, Carlsen H, Eijsink VGH, Mathiesen G. Front Microbiol. 2022 Jun 3. doi: 10.3389/fmicb.2022.900922. eCollection 2022.
- End-point definition and trial design to advance tuberculosis vaccine development. Garcia-Basteiro AL, White RG, Tait D, Schmidt AC, Rangaka MX, Quaife M, Nemes E, Mogg R, Hill PC, Harris RC, Hanekom WA, Frick M, Fiore-Gartland A, Evans T, Dagnew AF, Churchyard G, Cobelens F, Behr MA, Hatherill M. Eur Respir Rev. 2022 Jun 7. doi: 10.1183/16000617.0044-2022. Print 2022 Jun 30.
- Intravenous BCG driven antigen recognition in a murine tuberculosis model. Singh S, Bolz M, Cornelius A, Desvignes L. Comp Immunol Microbiol Infect Dis. 2022 Jun 7. doi: 10.1016/j.cimid.2022.101838. Online ahead of print.
- Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes. Jeyananthan V, Afkhami S, D’Agostino MR, Zganiacz A, Feng X, Miller MS, Jeyanathan M, Thompson MR, Xing Z. Front Immunol. 2022 Jun 10. doi: 10.3389/fimmu.2022.860399. eCollection 2022.
- The effect of BCG vaccination and risk factors for latent tuberculosis infection among college freshmen in China. Huang W, Fang Z, Luo S, Lin S, Xu L, Yan B, Yang Y, Liu X, Xia L, Fan X, Lu S. Int J Infect Dis. 2022 Jun 11. doi: 10.1016/j.ijid.2022.06.010. Online ahead of print.
- Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of Mycobacterium tuberculosis Sec Protein Export System. Nisa A, Counoupas C, Pinto R, Britton WJ, Triccas JA. Vaccines (Basel). 2022 Jun 14. doi: 10.3390/vaccines10060945.
- T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis. Steigler P, Chhiba M, Francis V, Keyser A, Abrahams D, Hanekom W, Ntsekhe M, Scriba TJ. Vaccine X. 2022 Jun 14. doi: 10.1016/j.jvacx.2022.100177. eCollection 2022 Aug.
- Adherence to Recommendations for Βacillus Calmette-Guérin Vaccination of High-risk Neonates in Greece. Maltezou HC, Magaziotou I, Tseroni M, Syrigonaki K, Syrogiannopoulos GA, Tsolia M, Roilides E, Theodoridou M, Georgakopoulou T. Pediatr Infect Dis J. 2022 Jun 22. doi: 10.1097/INF.0000000000003623. Online ahead of print.
- Review: Liposomes in the prophylaxis and treatment of infectious diseases. Azlyna ASN, Ahmad S, Husna SMN, Sarmiento ME, Acosta A, Norazmi MN, Mohamud R, Kadir R. Life Sci. 2022 Jun 24. doi: 10.1016/j.lfs.2022.120734. Online ahead of print.
- A next generation BCG vaccine moves forward. Dockrell HM. Lancet Infect Dis. 2022 Jun 27. doi: 10.1016/S1473-3099(22)00287-0. Online ahead of print.
- Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial. Cotton MF, Madhi SA, Luabeya AK, Tameris M, Hesseling AC, Shenje J, Schoeman E, Hatherill M, Desai S, Kapse D, Brückner S, Koen A, Jose L, Moultrie A, Bhikha S, Walzl G, Gutschmidt A, Kotze LA, Allies DL, Loxton AG, Shaligram U, Abraham M, Johnstone H, Grode L, Kaufmann SHE, Kulkarni PS. Lancet Infect Dis. 2022 Jun 27. doi: 10.1016/S1473-3099(22)00222-5. Online ahead of print.
- Safe use of intravesical bacillus Calmette-Guérin immunotherapy for bladder cancer during breastfeeding: a case report. Barbur E, Doganca T, Obek C. Immunotherapy. 2022 Jun 27. doi: 10.2217/imt-2021-0203. Online ahead of print.
- Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives. Saied AA, Metwally AA, Dhawan M, Choudhary OP, Aiash H. EMBO Mol Med. 2022 Jun 27. doi: 10.15252/emmm.202216287. Online ahead of print.
- Pathogenesis of tuberculosis: the 1930 Lübeck disaster revisited. Donald P, Kaufmann S, Thee S, Mandalakas AM, Lange C. Eur Respir Rev. 2022 Jun 28. doi: 10.1183/16000617.0046-2022. Print 2022 Jun 30.
- Multiplexed Strain Phenotyping Defines Consequences of Genetic Diversity in Mycobacterium tuberculosis for Infection and Vaccination Outcomes. Carey AF, Wang X, Cicchetti N, Spaulding CN, Liu Q, Hopkins F, Brown J, Sixsmith J, Sutiwisesak R, Behar SM, Ioerger TR, Fortune SM. mSystems. 2022 Jun 28. doi: 10.1128/msystems.00110-22. Epub 2022 Apr 18.
- Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice. Jia Q, Masleša-Galić S, Nava S, Horwitz MA. mBio. 2022 Jun 28. doi: 10.1128/mbio.00687-22. Epub 2022 Jun 1.
- Mouse Subcutaneous BCG Vaccination and Mycobacterium tuberculosis Infection Alter the Lung and Gut Microbiota. Silva F, Enaud R, Creissen E, Henao-Tamayo M, Delhaes L, Izzo A. Microbiol Spectr. 2022 Jun 29. doi: 10.1128/spectrum.01693-21. Epub 2022 Jun 2.
- Spontaneous Control of SIV Replication Does Not Prevent T Cell Dysregulation and Bacterial Dissemination in Animals Co-Infected with M. tuberculosis. Moriarty RV, Rodgers MA, Ellis AL, Balgeman AJ, Larson EC, Hopkins F, Chase MR, Maiello P, Fortune SM, Scanga CA, O’Connor SL. Microbiol Spectr. 2022 Jun 29. doi: 10.1128/spectrum.01724-21. Epub 2022 Apr 25